HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer

Bi Fei Huang, Huey En Tzeng, Po Chun Chen, Chao Qun Wang, Chen Ming Su, Yan Wang, Gui Nv Hu, Yong Ming Zhao, Qian Wang, Chih Hsin Tang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Breast cancer is a major cause of cancer mortality worldwide. High-mobility group box protein 1 (HMGB1) is a ubiquitous nuclear protein found in all mammal eukaryotic cells that participates in tumor progression, migration and metastasis. HMGB1 overexpression has been indicated in breast cancer patients. However, scant information is available regarding the association between HMGB1 single nucleotide polymorphisms (SNPs) and the risk or prognosis of breast cancer. We report on the association between 4 SNPs of the HMGB1 gene (rs1360485, rs1045411, rs2249825 and rs1412125) and breast cancer susceptibility as well as clinical outcomes in 313 patients with breast cancer and in 217 healthy controls. Patients with one G allele in the rs1360485 or rs2249825 domains are likely to progress to T2 tumor and lymph node metastasis. In addition, the presence of one G allele in SNPs rs1360485 or rs2249825 was associated with a higher risk of progressing to T2 tumor and distant metastasis amongst HER2-enriched and triple-negative breast cancer (TNBC) tumors compared with luminal A and luminal B tumors. Furthermore, having one C allele in the rs1412125 domain increased the risk of pathologic grade 3 disease in HER2-enriched and TNBC tumors. Our results indicate that genetic variations in the HMGB1 gene may serve as an important predictor of breast cancer progression and metastasis.

Original languageEnglish
Pages (from-to)580-586
Number of pages7
JournalInternational Journal of Medical Sciences
Volume15
Issue number6
DOIs
Publication statusPublished - Mar 12 2018

Fingerprint

HMGB1 Protein
Genetic Polymorphisms
Biomarkers
Breast Neoplasms
Triple Negative Breast Neoplasms
Neoplasm Metastasis
Single Nucleotide Polymorphism
Alleles
Neoplasms
Eukaryotic Cells
Nuclear Proteins
Genes
Mammals
Lymph Nodes
Mortality

Keywords

  • Breast cancer
  • HMGB1 polymorphisms
  • Single nucleotide polymorphism
  • Susceptibility

ASJC Scopus subject areas

  • Medicine(all)

Cite this

HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer. / Huang, Bi Fei; Tzeng, Huey En; Chen, Po Chun; Wang, Chao Qun; Su, Chen Ming; Wang, Yan; Hu, Gui Nv; Zhao, Yong Ming; Wang, Qian; Tang, Chih Hsin.

In: International Journal of Medical Sciences, Vol. 15, No. 6, 12.03.2018, p. 580-586.

Research output: Contribution to journalArticle

Huang, BF, Tzeng, HE, Chen, PC, Wang, CQ, Su, CM, Wang, Y, Hu, GN, Zhao, YM, Wang, Q & Tang, CH 2018, 'HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer', International Journal of Medical Sciences, vol. 15, no. 6, pp. 580-586. https://doi.org/10.7150/ijms.23462
Huang, Bi Fei ; Tzeng, Huey En ; Chen, Po Chun ; Wang, Chao Qun ; Su, Chen Ming ; Wang, Yan ; Hu, Gui Nv ; Zhao, Yong Ming ; Wang, Qian ; Tang, Chih Hsin. / HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer. In: International Journal of Medical Sciences. 2018 ; Vol. 15, No. 6. pp. 580-586.
@article{0d12faf0abd04ca8b56ed5b99398db92,
title = "HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer",
abstract = "Breast cancer is a major cause of cancer mortality worldwide. High-mobility group box protein 1 (HMGB1) is a ubiquitous nuclear protein found in all mammal eukaryotic cells that participates in tumor progression, migration and metastasis. HMGB1 overexpression has been indicated in breast cancer patients. However, scant information is available regarding the association between HMGB1 single nucleotide polymorphisms (SNPs) and the risk or prognosis of breast cancer. We report on the association between 4 SNPs of the HMGB1 gene (rs1360485, rs1045411, rs2249825 and rs1412125) and breast cancer susceptibility as well as clinical outcomes in 313 patients with breast cancer and in 217 healthy controls. Patients with one G allele in the rs1360485 or rs2249825 domains are likely to progress to T2 tumor and lymph node metastasis. In addition, the presence of one G allele in SNPs rs1360485 or rs2249825 was associated with a higher risk of progressing to T2 tumor and distant metastasis amongst HER2-enriched and triple-negative breast cancer (TNBC) tumors compared with luminal A and luminal B tumors. Furthermore, having one C allele in the rs1412125 domain increased the risk of pathologic grade 3 disease in HER2-enriched and TNBC tumors. Our results indicate that genetic variations in the HMGB1 gene may serve as an important predictor of breast cancer progression and metastasis.",
keywords = "Breast cancer, HMGB1 polymorphisms, Single nucleotide polymorphism, Susceptibility",
author = "Huang, {Bi Fei} and Tzeng, {Huey En} and Chen, {Po Chun} and Wang, {Chao Qun} and Su, {Chen Ming} and Yan Wang and Hu, {Gui Nv} and Zhao, {Yong Ming} and Qian Wang and Tang, {Chih Hsin}",
year = "2018",
month = "3",
day = "12",
doi = "10.7150/ijms.23462",
language = "English",
volume = "15",
pages = "580--586",
journal = "International Journal of Medical Sciences",
issn = "1449-1907",
publisher = "Ivyspring International Publisher",
number = "6",

}

TY - JOUR

T1 - HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer

AU - Huang, Bi Fei

AU - Tzeng, Huey En

AU - Chen, Po Chun

AU - Wang, Chao Qun

AU - Su, Chen Ming

AU - Wang, Yan

AU - Hu, Gui Nv

AU - Zhao, Yong Ming

AU - Wang, Qian

AU - Tang, Chih Hsin

PY - 2018/3/12

Y1 - 2018/3/12

N2 - Breast cancer is a major cause of cancer mortality worldwide. High-mobility group box protein 1 (HMGB1) is a ubiquitous nuclear protein found in all mammal eukaryotic cells that participates in tumor progression, migration and metastasis. HMGB1 overexpression has been indicated in breast cancer patients. However, scant information is available regarding the association between HMGB1 single nucleotide polymorphisms (SNPs) and the risk or prognosis of breast cancer. We report on the association between 4 SNPs of the HMGB1 gene (rs1360485, rs1045411, rs2249825 and rs1412125) and breast cancer susceptibility as well as clinical outcomes in 313 patients with breast cancer and in 217 healthy controls. Patients with one G allele in the rs1360485 or rs2249825 domains are likely to progress to T2 tumor and lymph node metastasis. In addition, the presence of one G allele in SNPs rs1360485 or rs2249825 was associated with a higher risk of progressing to T2 tumor and distant metastasis amongst HER2-enriched and triple-negative breast cancer (TNBC) tumors compared with luminal A and luminal B tumors. Furthermore, having one C allele in the rs1412125 domain increased the risk of pathologic grade 3 disease in HER2-enriched and TNBC tumors. Our results indicate that genetic variations in the HMGB1 gene may serve as an important predictor of breast cancer progression and metastasis.

AB - Breast cancer is a major cause of cancer mortality worldwide. High-mobility group box protein 1 (HMGB1) is a ubiquitous nuclear protein found in all mammal eukaryotic cells that participates in tumor progression, migration and metastasis. HMGB1 overexpression has been indicated in breast cancer patients. However, scant information is available regarding the association between HMGB1 single nucleotide polymorphisms (SNPs) and the risk or prognosis of breast cancer. We report on the association between 4 SNPs of the HMGB1 gene (rs1360485, rs1045411, rs2249825 and rs1412125) and breast cancer susceptibility as well as clinical outcomes in 313 patients with breast cancer and in 217 healthy controls. Patients with one G allele in the rs1360485 or rs2249825 domains are likely to progress to T2 tumor and lymph node metastasis. In addition, the presence of one G allele in SNPs rs1360485 or rs2249825 was associated with a higher risk of progressing to T2 tumor and distant metastasis amongst HER2-enriched and triple-negative breast cancer (TNBC) tumors compared with luminal A and luminal B tumors. Furthermore, having one C allele in the rs1412125 domain increased the risk of pathologic grade 3 disease in HER2-enriched and TNBC tumors. Our results indicate that genetic variations in the HMGB1 gene may serve as an important predictor of breast cancer progression and metastasis.

KW - Breast cancer

KW - HMGB1 polymorphisms

KW - Single nucleotide polymorphism

KW - Susceptibility

UR - http://www.scopus.com/inward/record.url?scp=85045187011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045187011&partnerID=8YFLogxK

U2 - 10.7150/ijms.23462

DO - 10.7150/ijms.23462

M3 - Article

AN - SCOPUS:85045187011

VL - 15

SP - 580

EP - 586

JO - International Journal of Medical Sciences

JF - International Journal of Medical Sciences

SN - 1449-1907

IS - 6

ER -